NCT00245674View on ClinicalTrials.gov

SOLIACS: Solian Solution in the Acute Setting

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 30, 2005

Conditions
Schizophrenia
Interventions
DRUG

amisulpride

Trial Locations (1)

Unknown

Sanofi-aventis, Diegem

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00245674 - SOLIACS: Solian Solution in the Acute Setting | Biotech Hunter | Biotech Hunter